Coeliac disease and primary hyperparathyroidism: An association?

Postgraduate Medical Journal

Volumn 82, Issue 974, 2006, Pages 833-835

  Maida, M J ^a   Praveen, E ^a   Crimmins, S R ^a   Swift, G L ^a  

^a LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCICHEW D3 FORTE; CALCIUM CARBONATE; CALCIUM CARBONATE PLUS COLECALCIFEROL; COLECALCIFEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUTEN FREE DIET; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MALE; OSTEOPOROSIS; PARATHYROID ADENOMA; PARATHYROIDECTOMY; PREVALENCE; PRIMARY HYPERPARATHYROIDISM;

ADENOMA; AGED; CELIAC DISEASE; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MIDDLE AGED; PARATHYROID NEOPLASMS;

EID: 33846187578     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2006.045500     Document Type: Article

References (15)

1. Kamin DS, Furuta GT. The iceberg cometh: establishing the prevalence of celiac disease in the United States and Finland. Gastroenterology 2004;127:359-61.
2. Green PH, Jabri B. Coeliac disease. Lancet 2003;362:383-91.
3. Holmes GKT, Stokes PL, Sorahan TM, et al. Coeliac disease, gluten free diet and malignancy. Gut 1976;17:612-19.
4. Catassi C, Fabiani E, Corrao G, et al. Risk of non-Hodgkin's lymphoma in celiac disease. JAMA 2002;287:1413-19.
5. Ventura A, Magazzu G, Greco L, et al. Duration of exposure to gluten and risk of autoimmune disorders in patients with coeliac disease. Gastroenterology 1999;117:297-303.
6. Sategna-Guidetti C, Solerio E, Scaglione N, et al. Duration of gluten exposure in adult celiac disease does not correlate with the risk for autoimmune disorders. Gut 2001;49:502-5.
7. al Zahrani A, Levine MA. Primary hyperparathyroidism. Lancet 1997;349:1233-8.
8. Gannage MH, Abikaram G, Nasr F, et al. Osteomalacia secondary to celiac disease, primary hyperparathyroidism and Grave's disease. Amer J Med Sci 1998;315:136-9.
9. Heath H, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: incidence, morbidity and potential economic impact in a community. N Engl J Med 1980;302:189-93.
10. Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 2002;17(Suppl 2):N18-23.
11. Krause MW, Hedinger CE. Pathologic study of parathyroid glands in tertiary hyperparathyroidism. Hum Pathol 1985;16:772-84.
12. Farnebo F, Enberg U, Grimelius L, et al. Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism. Clin Endocrinol Metab 1997;82:3481-6.
13. Yano S, Sugimoto T. Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism. Kidney Int 2000;58:1980-6.
14. Collin P, Reunala T, Pukkala E, et al. Coeliac disease-associated disorders and survival. Gut 1994;35:1215-18.
15. O'Leary C. Coeliac disease and autoimmune Addison's disease: a clinical pitfall. QJM 2002;95:79-82.